FDA Falsely Denied Pancreatic Cancer Risk in Diabetes Medications
In 2013, the FDA released an assessment that said they did not see a link between the incretin class of drugs (Byetta, Byudreon, Victoza, Januvia, Janumet, and Tanzeum) and pancreatic cancer. However, the BMJ recently published a study that incretin drugs do in fact increase a person’s risk of pancreatic cancer. About Incretin Medications
Read MoreConsumer Alert! Byetta Pancreatic Cancer Association
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. First Actos was linked to bladder cancer, now Byetta to pancreatic cancer. The diabetes drug Byetta has a long history of safety problems ranging from pancreatitis to renal failure. However, the warnings signs have taken on an entirely different meaning in
Read MoreByetta Linked to Cancer In Rat Studies
This bad news for consumers as well as bad news for Eli Lilly and Amlyn Pharmaceuticals. Recent studies have shown an increase of instances of thyroid cancer in rats treated with Byetta. It appears the drug may be following in the footsteps Novo Nordisk’s competing Victoza, which hold a similar warning. Granted, the Byetta dose
Read More